{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T12:58:32Z","timestamp":1765112312832},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T00:00:00Z","timestamp":1239840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Abdom Imaging"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00261-009-9516-9","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T19:05:28Z","timestamp":1239822328000},"page":"232-240","source":"Crossref","is-referenced-by-count":20,"title":["Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET\/CT"],"prefix":"10.1007","volume":"35","author":[{"given":"Ukihide","family":"Tateishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Terauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,16]]},"reference":[{"key":"9516_CR1","first-page":"1326","volume":"47","author":"YS Jhanwar","year":"2006","unstructured":"Jhanwar YS, Straus DJ. The role of PET in lymphoma. J Nucl Med 2006; 47:1326-1334","journal-title":"J Nucl Med"},{"key":"9516_CR2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/cncr.21253","volume":"104","author":"CR Isasi","year":"2005","unstructured":"Isasi CR, Lu P, Blaufox MD. A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma. Cancer 2005; 104:1066-1074","journal-title":"Cancer"},{"key":"9516_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.semnuclmed.2005.02.003","volume":"35","author":"RJ Hicks","year":"2005","unstructured":"Hicks RJ, Mac Manus MP, Seymour JF. Initial staging of lymphoma with positron emission tomography and computed tomography. Semin Nucl Med 2005; 35:165-175","journal-title":"Semin Nucl Med"},{"key":"9516_CR4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.rcl.2007.05.008","volume":"45","author":"DA Podoloff","year":"2007","unstructured":"Podoloff DA, Macapinlac HA. PET and PET\/CT in management of the lymphomas. Radiol Clin North Am 2007; 45:689-696","journal-title":"Radiol Clin North Am"},{"key":"9516_CR5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.rcl.2004.08.008","volume":"42","author":"R Kumar","year":"2004","unstructured":"Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas. Radiol Clin North Am 2004; 42:1083-1100","journal-title":"Radiol Clin North Am"},{"key":"9516_CR6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2004.05069.x","volume":"126","author":"C Burton","year":"2004","unstructured":"Burton C, Ell P, Linch D. The role of PET imaging in lymphoma. Br J Haematol 2004; 126:772-784","journal-title":"Br J Haematol"},{"key":"9516_CR7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1148\/radiol.2463060588","volume":"246","author":"GA Ulaner","year":"2008","unstructured":"Ulaner GA, Colletti PM, Conti PS. B-cell non-Hodgkin lymphoma: PET\/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy\u2013initial experience. Radiology 2008; 246:895-902","journal-title":"Radiology"},{"key":"9516_CR8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","volume":"107","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006; 107:52-59","journal-title":"Blood"},{"key":"9516_CR9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdi093","volume":"16","author":"KP Beal","year":"2005","unstructured":"Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 2005; 16:473-480","journal-title":"Ann Oncol"},{"key":"9516_CR10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cncr.21967","volume":"107","author":"M Karam","year":"2006","unstructured":"Karam M, Novak L, Cyriac J, et al. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 2006; 107:175-183","journal-title":"Cancer"},{"key":"9516_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2133.2006.07367.x","volume":"155","author":"R Kumar","year":"2006","unstructured":"Kumar R, Xiu Y, Zhuang HM, Alavi A. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma. Br J Dermatol 2006; 155:357-363","journal-title":"Br J Dermatol"},{"key":"9516_CR12","first-page":"577","volume":"142","author":"EY Tsai","year":"2006","unstructured":"Tsai EY, Taur A, Espinosa L, et al. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol 2006; 142:577-584","journal-title":"Arch Dermatol"},{"key":"9516_CR13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/annonc\/mdl014","volume":"17","author":"S Wohrer","year":"2006","unstructured":"Wohrer S, Jaeger U, Kletter K, et al.18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol 2006; 17:780-784","journal-title":"Ann Oncol"},{"key":"9516_CR14","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1259\/bjr\/31280356","volume":"80","author":"E Ghersin","year":"2007","unstructured":"Ghersin E, Keidar Z, Eldad DJ, et al. Multimodality imaging of direct ureteric involvement in non-Hodgkin\u2019s lymphoma using PET\/CT, CT urography and antegrade CT pyelography. Br J Radiol 2007; 80:e283-286","journal-title":"Br J Radiol"},{"key":"9516_CR15","first-page":"145","volume":"33","author":"MM Abouzied","year":"2005","unstructured":"Abouzied MM, Crawford ES, Nabi HA.18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol 2005; 33:145-155","journal-title":"J Nucl Med Technol"},{"key":"9516_CR16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1148\/radiographics.18.4.9672967","volume":"18","author":"HJ Vesselle","year":"1998","unstructured":"Vesselle HJ, Miraldi FD. FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics 1998; 18:805-823","journal-title":"Radiographics"},{"key":"9516_CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1148\/radiol.2382041977","volume":"238","author":"GK Schulthess von","year":"2006","unstructured":"von Schulthess GK, Steinert HC, Hany TF. Integrated PET\/CT: current applications and future directions. Radiology 2006; 238:405-422","journal-title":"Radiology"},{"key":"9516_CR18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.mibio.2004.08.004","volume":"6","author":"M Allen-Auerbach","year":"2004","unstructured":"Allen-Auerbach M, Quon A, Weber WA, et al. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography\/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol 2004; 6:411-416","journal-title":"Mol Imaging Biol"},{"key":"9516_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00259-003-1375-y","volume":"31","author":"LS Freudenberg","year":"2004","unstructured":"Freudenberg LS, Antoch G, Schutt P, et al. FDG-PET\/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging 2004; 31:325-329","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9516_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdj024","volume":"17","author":"P Raanani","year":"2006","unstructured":"Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET\/CT era? Ann Oncol 2006; 17:117-122","journal-title":"Ann Oncol"},{"key":"9516_CR21","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejrad.2007.08.017","volume":"67","author":"T Morimoto","year":"2007","unstructured":"Morimoto T, Tateishi U, Maeda T, et al. Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: Comparison of integrated PET\/CT with or without contrast enhancement. Eur J Radiol 2007; 67:508-513","journal-title":"Eur J Radiol"},{"key":"9516_CR22","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00259-007-0504-4","volume":"34","author":"P Vera","year":"2007","unstructured":"Vera P, Ouvrier MJ, Hapdey S, et al. Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET\/CT in lymphoma? Eur J Nucl Med Mol Imaging 2007; 34:1943-1952","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9516_CR23","first-page":"1643","volume":"47","author":"B Rodr\u00edguez-Vigil","year":"2006","unstructured":"Rodr\u00edguez-Vigil B, G\u00f3mez-Le\u00f3n N, Pinilla I, et al. PET\/CT in lymphoma: prospective study of enhanced full-dose PET\/CT versus unenhanced low-dose PET\/CT. J Nucl Med 2006; 47:1643-1648","journal-title":"J Nucl Med"},{"key":"9516_CR24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.rcl.2007.05.009","volume":"45","author":"E Even-Sapir","year":"2007","unstructured":"Even-Sapir E, Lievshitz G, Perry C, et al. Fluorine-18 fluorodeoxyglucose PET\/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin\u2019s disease. Radiol Clin North Am 2007; 45:697-709","journal-title":"Radiol Clin North Am"},{"key":"9516_CR25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rcl.2007.05.006","volume":"45","author":"R Bar-Shalom","year":"2007","unstructured":"Bar-Shalom R. Normal and abnormal patterns of 18F-fluorodeoxyglucose PET\/CT in lymphoma. Radiol Clin North Am 2007; 45:677-688","journal-title":"Radiol Clin North Am"},{"key":"9516_CR26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0609.2007.00895.x","volume":"79","author":"C Perry","year":"2007","unstructured":"Perry C, Herishanu Y, Metzer U, et al. Diagnostic accuracy of PET\/CT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol 2007; 79:205-209","journal-title":"Eur J Haematol"},{"key":"9516_CR27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mibio.2004.04.002","volume":"6","author":"HA Macapinlac","year":"2004","unstructured":"Macapinlac HA. The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma. Mol Imaging Biol 2004; 6:200-207","journal-title":"Mol Imaging Biol"},{"key":"9516_CR28","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1148\/radiol.2373040555","volume":"237","author":"M Tatsumi","year":"2005","unstructured":"Tatsumi M, Cohade C, Nakamoto Y, Fishman EK, Wahl RL. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience. Radiology 2005; 237:1038-1045","journal-title":"Radiology"},{"key":"9516_CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1148\/radiol.2441060810","volume":"244","author":"NG Schaefer","year":"2007","unstructured":"Schaefer NG, Taverna C, Strobel K, et al. Hodgkin disease: diagnostic value of FDG PET\/CT after first-line therapy\u2014is biopsy of FDG-avid lesions still needed? Radiology 2007; 244:257-262","journal-title":"Radiology"},{"key":"9516_CR30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/j.cpradiol.2006.02.001","volume":"35","author":"B Rodriguez-Vigil","year":"2006","unstructured":"Rodriguez-Vigil B, Gomez-Leon N, Pinilla I, et al. Positron emission tomography\/computed tomography in the management of Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Curr Probl Diagn Radiol 2006; 35:151-163","journal-title":"Curr Probl Diagn Radiol"},{"key":"9516_CR31","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/BF01367602","volume":"23","author":"LG Strauss","year":"1996","unstructured":"Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996; 23:1409-1415","journal-title":"Eur J Nucl Med"},{"key":"9516_CR32","first-page":"441","volume":"7","author":"GJR Cook","year":"1996","unstructured":"Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 7:441-446","journal-title":"Semin Nucl Med"},{"key":"9516_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2006.06284.x","volume":"135","author":"D Hernandez-Maraver","year":"2006","unstructured":"Hernandez-Maraver D, Hernandez-Navarro F, Gomez-Leon N, et al. Positron emission tomography\/computed tomography: diagnostic accuracy in lymphoma. Br J Haematol 2006; 135:293-302","journal-title":"Br J Haematol"},{"key":"9516_CR34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00259-006-0171-x","volume":"33","author":"C la Foug\u00e8re","year":"2006","unstructured":"la Foug\u00e8re C, Hundt W, Br\u00f6ckel N, et al. Value of PET\/CT versus PET and CT performed as separate investigations in patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Eur J Nucl Med Mol Imaging 2006; 33:1417-1425","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9516_CR35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.mph.0000212912.37512.b1","volume":"28","author":"MM Rhodes","year":"2006","unstructured":"Rhodes MM, Delbeke D, Whitlock JA, et al. Utility of FDG-PET\/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. J Pediatr Hematol Oncol 2006; 28:300-306","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Abdominal Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-009-9516-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-009-9516-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-009-9516-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:17:03Z","timestamp":1558714623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-009-9516-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,16]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["9516"],"URL":"https:\/\/doi.org\/10.1007\/s00261-009-9516-9","relation":{},"ISSN":["0942-8925","1432-0509"],"issn-type":[{"value":"0942-8925","type":"print"},{"value":"1432-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,16]]}}}